Literature DB >> 27298757

Giant Cell Arteritis: From Pathogenesis to Therapeutic Management.

Ryu Watanabe1, Jörg J Goronzy1, Gerald Berry2, Y Joyce Liao3, Cornelia M Weyand1.   

Abstract

Entities:  

Keywords:  endothelial cells; giant cell arteritis; immunosuppression; macrophages; proinflammatory T cells; vascular smooth muscle cells

Year:  2016        PMID： 27298757      PMCID： PMC4902281          DOI： 10.1007/s40674-016-0043-x

Source DB:  PubMed          Journal:  Curr Treatm Opt Rheumatol        ISSN： 2198-6002


× No keyword cloud information.
  64 in total

1.  Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis.

Authors:  Carlos Gonzalez-Juanatey; Javier Llorca; Carlos Garcia-Porrua; Amalia Sanchez-Andrade; Javier Martín; Miguel A Gonzalez-Gay
Journal:  J Rheumatol       Date:  2006-01       Impact factor: 4.666

Review 2.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

3.  Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment.

Authors:  M C Cid; E Campo; G Ercilla; A Palacin; J Vilaseca; J Villalta; M Ingelmo
Journal:  Arthritis Rheum       Date:  1989-07

4.  Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.

Authors:  Mattia Baldini; Norma Maugeri; Giuseppe A Ramirez; Chiara Giacomassi; Alessandra Castiglioni; Sergio Prieto-González; Marc Corbera-Bellalta; Gabriele Di Comite; Ilenia Papa; Giacomo Dell'antonio; Enrico Ammirati; Ivan Cuccovillo; Viviana Vecchio; Alberto Mantovani; Patrizia Rovere-Querini; Maria Grazia Sabbadini; Maria C Cid; Angelo A Manfredi
Journal:  Arthritis Rheum       Date:  2012-03

5.  Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.

Authors:  A D Wagner; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.

Authors:  N E Roche; J W Fulbright; A D Wagner; G G Hunder; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1993-09

7.  Vessel-specific Toll-like receptor profiles in human medium and large arteries.

Authors:  Olga Pryshchep; Wei Ma-Krupa; Brian R Younge; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

8.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

Review 9.  The molecular cell biology of interferon-gamma and its receptor.

Authors:  M A Farrar; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

10.  Cytokine-induced generation of multinucleated giant cells in vitro requires interferon-gamma and expression of LFA-1.

Authors:  J Möst; H P Neumayer; M P Dierich
Journal:  Eur J Immunol       Date:  1990-08       Impact factor: 5.532
View more
  16 in total

Review 1.  Immune checkpoint dysfunction in large and medium vessel vasculitis.

Authors:  Ryu Watanabe; Hui Zhang; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

Review 2.  Vasculitogenic T Cells in Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Motomu Hashimoto
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

Review 3.  Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis.

Authors:  Ryu Watanabe; Ebru Hosgur; Hui Zhang; Zhenke Wen; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Joint Bone Spine       Date:  2016-09-20       Impact factor: 4.929

Review 4.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

Review 5.  Mechanism and biomarkers in aortitis--a review.

Authors:  Benjamin Benhuri; Ammar ELJack; Bashar Kahaleh; Ritu Chakravarti
Journal:  J Mol Med (Berl)       Date:  2019-10-30       Impact factor: 4.599

Review 6.  The Treatment of Giant Cell Arteritis in Different Clinical Settings.

Authors:  Alexander Pfeil; Peter Oelzner; Peter Hellmann
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

7.  An inflammatory milieu: Optic perineuritis, retroperitoneal fibrosis, and giant cell arteritis.

Authors:  Doria M Gold; Steven L Galetta
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-11-26

Review 8.  Cellular Signaling Pathways in Medium and Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 9.  Profile of tocilizumab and its potential in the treatment of giant cell arteritis.

Authors:  Susan Patricia Mollan; John Horsburgh; Bhaskar Dasgupta
Journal:  Eye Brain       Date:  2018-01-23

10.  Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA.

Authors:  Rebeca Hid Cadena; Rosanne D Reitsema; Minke G Huitema; Yannick van Sleen; Kornelis S M van der Geest; Peter Heeringa; Annemieke M H Boots; Wayel H Abdulahad; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.